BackYD Bio Limited Ordinary Shares Overview

YD Bio Limited Ordinary Shares Current Assets

YD Bio Limited Ordinary Shares's current assets is $9.7M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$9.67M
178.85% YoYΔ $6.20M vs prior year quarter

Peer average

Loading

YD Bio Limited Ordinary Shares Current Assets History

Loading

YD Bio Limited Ordinary Shares vs. peers: Current Assets Comparison

Loading

YD Bio Limited Ordinary Shares Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

YD Bio Limited Ordinary Shares (YDES) FAQ

As of the most recent data (December 2025), YDES shows a current assets of $9.7M. That compares with $3.5M in the prior-year period — up 178.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, YDES's current assets is now $9.7M (was $3.5M) — a 178.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether YD Bio Limited Ordinary Shares is outperforming or lagging.

Tracking YDES's current assets over time shows whether YD Bio Limited Ordinary Shares is scaling, shrinking, or reshaping that part of the business. The current reading is $9.7M That compares with $3.5M in the prior-year period — up 178.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has YD Bio Limited Ordinary Shares's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $9.7M) with ownership activity and broader fundamentals.

YD Bio Limited Ordinary Shares's current assets is $9.7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.